Stoneridge Investment Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,263
| Closed | -$774K | – | 134 |
|
|
2025
Q3 | $774K | Buy |
+10,263
| New | +$703K | 0.53% | 59 |
|
|
2025
Q1 | – | Sell |
-207,651
| Closed | -$9.32M | – | 124 |
|
|
2024
Q4 | $9.32M | Buy |
207,651
+152,296
| +275% | +$8.54M | 3.33% | 5 |
|
|
2024
Q3 | $3.48M | Sell |
55,355
-16,814
| -23% | -$981K | 1.29% | 25 |
|
|
2024
Q2 | $4.26M | Buy |
+72,169
| New | +$4.51M | 1.61% | 17 |
|
|
2023
Q4 | – | Sell |
-90,806
| Closed | -$6.34M | – | 96 |
|
|
2023
Q3 | $6.34M | Sell |
90,806
-19,006
| -17% | -$1.35M | 2.99% | 5 |
|
|
2023
Q2 | $7.59M | Buy |
+109,812
| New | +$7.81M | 3.3% | 4 |
|
|
2022
Q4 | – | Sell |
-25,100
| Closed | -$2.39M | – | 97 |
|
|
2022
Q3 | $2.39M | Buy |
25,100
+12,700
| +102% | +$1.26M | 1.41% | 24 |
|
|
2022
Q2 | $1.15M | Buy |
+12,400
| New | +$1.21M | 0.63% | 48 |
|
|
2021
Q3 | – | Sell |
-8,850
| Closed | -$738K | – | 118 |
|
|
2021
Q2 | $738K | Sell |
8,850
-34,128
| -79% | -$2.79M | 0.36% | 73 |
|
|
2021
Q1 | $3.23M | Sell |
42,978
-13,175
| -23% | -$960K | 1.7% | 15 |
|
|
2020
Q4 | $3.83M | Sell |
56,153
-496
| -0.9% | -$32.3K | 2.22% | 12 |
|
|
2020
Q3 | $3.31M | Sell |
56,649
-48,337
| -46% | -$3.01M | 2.18% | 10 |
|
|
2020
Q2 | $6.82M | Buy |
104,986
+27,181
| +35% | +$1.71M | 2.87% | 5 |
|
|
2020
Q1 | $4.62M | Buy |
77,805
+19,647
| +34% | +$1.31M | 2.08% | 12 |
|
|
2019
Q4 | $4.32M | Sell |
58,158
-800
| -1% | -$56.2K | 1.46% | 17 |
|
|
2019
Q3 | $3.72M | Sell |
58,958
-53,554
| -48% | -$3.17M | 1.37% | 21 |
|
|
2019
Q2 | $6.13M | Sell |
112,512
-21,078
| -16% | -$1.14M | 2.18% | 9 |
|
|
2019
Q1 | $7.21M | Buy |
133,590
+57
| +0% | +$3.52K | 2.12% | 7 |
|
|
2018
Q4 | $8.75M | Buy |
133,533
+34,749
| +35% | +$2.59M | 2.74% | 6 |
|
|
2018
Q3 | $7.78M | Sell |
98,784
-13,882
| -12% | -$992K | 1.65% | 12 |
|
|
2018
Q2 | $7.25M | Buy |
112,666
+9,053
| +9% | +$597K | 1.4% | 20 |
|
|
2018
Q1 | $6.45M | Buy |
103,613
+67,331
| +186% | +$4.83M | 1.08% | 40 |
|
|
2017
Q4 | $2.63M | Sell |
36,282
-1,151
| -3% | -$83.7K | 0.42% | 80 |
|
|
2017
Q3 | $3.04M | Sell |
37,433
-5,498
| -13% | -$435K | 0.48% | 84 |
|
|
2017
Q2 | $3.45M | Sell |
42,931
-73,292
| -63% | -$5.79M | 0.51% | 77 |
|
|
2017
Q1 | $9.12M | Sell |
116,223
-37,855
| -25% | -$3.02M | 1.23% | 11 |
|
|
2016
Q4 | $12.2M | Sell |
154,078
-300
| -0.2% | -$24.3K | 1.65% | 6 |
|
|
2016
Q3 | $13.7M | Sell |
154,378
-32,115
| -17% | -$3.03M | 1.99% | 4 |
|
|
2016
Q2 | $17.9M | Buy |
186,493
+10,117
| +6% | +$1.01M | 2.66% | 2 |
|
|
2016
Q1 | $18.3M | Sell |
176,376
-5,675
| -3% | -$552K | 2.68% | 2 |
|
|
2015
Q4 | $17.8M | Buy |
182,051
+64,804
| +55% | +$6.35M | 2.4% | 3 |
|
|
2015
Q3 | $11.3M | Buy |
117,247
+29,981
| +34% | +$3.15M | 1.59% | 12 |
|
|
2015
Q2 | $9.15M | Sell |
87,266
-11,334
| -11% | -$1.16M | 1.13% | 19 |
|
|
2015
Q1 | $10.2M | Buy |
98,600
+13,614
| +16% | +$1.38M | 1.19% | 13 |
|
|
2014
Q4 | $8.19M | Sell |
84,986
-400
| -0.5% | -$35.2K | 1.08% | 17 |
|
|
2014
Q3 | $6.8M | Buy |
85,386
+380
| +0.4% | +$30K | 1.01% | 19 |
|
|
2014
Q2 | $6.41M | Sell |
85,006
-1,950
| -2% | -$147K | 0.96% | 27 |
|
|
2014
Q1 | $6.51M | Sell |
86,956
-2,300
| -3% | -$162K | 1.26% | 27 |
|
|
2013
Q4 | $6.39M | Sell |
89,256
-15,673
| -15% | -$1.01M | 1.23% | 24 |
|
|
2013
Q3 | $5.96M | Buy |
104,929
+18,586
| +22% | +$1.11M | 1.3% | 26 |
|
|
2013
Q2 | $4.94M | Buy |
+86,343
| New | +$5M | 1.15% | 29 |
|
Other funds holding CVS
Stoneridge Investment Partners's CVS Position: Q4 2025 in Review
Stoneridge Investment Partners sold out of CVS Health (CVS) in Q4 2025, closing a stake of 10,263 shares — an estimated $774K sold.
Stoneridge Investment Partners first reported a position in CVS in Q2 2013 and held it in 41 quarters. The position peaked at $18.3M in Q1 2016. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Stoneridge Investment Partners reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Stoneridge Investment Partners sold 10,263 CVS Health shares in Q4 2025, an estimated $774K.
- Stoneridge Investment Partners first reported a position in CVS Health in Q2 2013 and held it in 41 quarters.
- Stoneridge Investment Partners's CVS Health position peaked at $18.3M in Q1 2016.
- 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Stoneridge Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.